In just over a year, Elaine Birkemeyer has transformed the financial position of Tactile Medical, a company devoted to lymphedema, lipedema and chronic venous insufficiency via at-home treatments.

Ellingsen has lipedema, a condition that causes tissue buildup in her arms and legs ... Houston promised to reimburse their expenses and legal fees, and pay for Brady's future treatment. He also asked ...

With a shared commitment to address the unmet needs of patients and families impacted by mBC, Arvinas and Pfizer are collaborating to explore the potential use of a novel technology that may offer a ...

The dark skies during a new moon provide ideal conditions for spotting skywatching targets that would otherwise be outshined by moonlight. The next new moon will occur on Sunday, Dec. 1 at 1:21 a ...

Researchers have found a new treatment protocol that may help some people with this deadly cancer to survive longer. News 8’s Brittany Noble has details in Thursday’s Health Spotlight.

A woman who was forced to seek out-of-country treatment for her painful chronic condition says she welcomes a recent apology ...

It’s happening right now for other Nova Scotians,” said Ellingsen, a 46-year-old mother of three who has spent years fighting for in-province lipedema treatment. Nova Scotia Supreme Court ...

A woman who was forced to seek out-of-country treatment that cost more than $100,000 for her agonizing chronic condition said she welcomes a recent apology from Nova Scotia’s premier ...

THE CANADIAN PRESS/HO-Lipedema Canada-Jenny White *MANDATORY CREDIT * A woman who was forced to seek out-of-country treatment for her painful chronic condition says she welcomes a recent apology ...

New treatments for Alzheimer disease don’t reverse cognitive symptoms, but they do significantly slow progression. Evidence suggests that earlier treatment is most effective. In his first ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments. One of these, lecanemab ...

Most patients die within 10 to 20 years after symptoms first appear. The new treatment leverages peptide-brush polymers, which act as a shield to prevent proteins from binding to one another.